Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00820716
Other study ID # 3825
Secondary ID 2006-A00090-51
Status Terminated
Phase N/A
First received
Last updated
Start date September 21, 2009
Est. completion date October 15, 2010

Study information

Verified date August 2011
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to compare two methods of exercise training: alternate load versus constant load realized at moderate or high intensities, in order to define the interests and the limits of each one of these two methods. The finality is to make possible to the expert to choose what exercise training induces the best results quickly and to make its choice according to the therapeutic objectives which it lays down.We also evaluate the effects of these exercises training on the vagal response and the bronchial tone of the asthmatics. From a clinical point of view, a close attention will be paid to the effects of these exercises training on the control of asthma and the quality of life of the subjects


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date October 15, 2010
Est. primary completion date October 15, 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- 18 to 45 years old

- mild to moderate persistent asthma (GINA classification)

- stabilized asthma

- physical activity level between 5 and 11 (Baecke and coll, 1982)

- no contra-indication for physical training

Exclusion Criteria:

- cardiovascular pathology

- metabolic pathology

- traumatic pathology

- BMI=30

- tobacco

- diabetes

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise training
Comparison of two methods of exercise training: alternate load versus constant load realized at moderate or high intensities

Locations

Country Name City State
France Service de Physiologie et d'Explorations Fonctionnelles - Pôle de Pathologie Thoracique - Nouvel Hôpital Civil Strasbourg
France Service de Pneumologie - Pôle de Pathologie Thoracique - Nouvel Hôpital Civil Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal oxygen consumption (VO2max) At T-1 = eight weeks before training - At T0 = beginning of training - At T1 = eight weeks after training
Primary Maximal power output (Pmax) At T-1 = eight weeks before training - At T0 = beginning of training - At T1 = eight weeks after training
Secondary Exhaled NO (eNO) At T-1 = eight weeks before training - At T0 = beginning of training - At T1 = eight weeks after training
Secondary Heart rate variability At T-1 = eight weeks before training - At T0 = beginning of training - At T1 = eight weeks after training
Secondary Force Expiratory Volume in one second (FEV1) At T-1 = eight weeks before training - At T0 = beginning of training - At T1 = eight weeks after training
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device